-
EMUC23 tackles current challenges of PSMA PET/CT in PCa
November 2, 2023Plenary Session 5 “Nuclear medicine in urology: Lessons learnt and new horizons” of the EAU Section of Urological Imaging (ESUI)...
00 -
ESUI meeting examines novel imaging trials
November 2, 2023Today, Plenary Session 3 of the EAU Section of Urological Imaging (ESUI) meeting examined the latest evidence in three...
-
ESUI: Getting ready for the new EU approach to PCa screening
November 2, 2023This year, the annual EAU Section of Urological Imaging (ESUI) meeting has been integrated into the 15th European Multidisciplinary...
-
EMUC23: GU cancer game-changers for 2023
September 14, 2023A collaborative approach to reviewing trials prevents tunnel vision Collaborative efforts are required to drive game-changing advancements in medical...
-
Adverse events: Cornerstone for safer pathways?
August 14, 2023Learning points from morbidity and mortality Adverse events can positively transform new approaches in patient management. How? By applying...
-
Synergy of specialties at EMUC23: Why MDTs are paramount to optimal patient care
June 7, 2023Throughout the years, the European Multidisciplinary Congress on Urological Cancers (EMUC) has garnered a loyal following and a steady growth...
-
AI opportunities in GU Cancers
November 12, 2022Looking to the future, Prof. Arnulf Stenzl (DE), Prof. Alberto Briganti (IT) and Dr. Bob Schijvenaars (NL) chaired the...
-
New trial results for PEACE-1, OpeRa, and adjuvant therapies in high-risk RCC
November 12, 2022A selection of new trial results were shared and discussed in Plenary Session 5 on day three of EMUC22....
-
Plenary Session 3 report: New strategies in BCa
November 11, 2022After a day full of supplementary meetings like ESUI22 and the YAU’s Autumn Meeting, day two of EMUC22 saw...
-
Diagnosing PCa – what’s the best option?
November 11, 2022The objective of the 14th European Multidisciplinary Congress on Urological Cancers is to work together to achieve the best...
News
EMUC24 > News
